We are live on ! Find out more
EC

Euclidean Capital Portfolio holdings

AUM $392M
1-Year Est. Return 31.85%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+31.85%
3 Year Est. Return
+76.27%
5 Year Est. Return
-20.16%
10 Year Est. Return
–
AUM
$392M
AUM Growth
+$22.9M
Cap. Flow
+$14M
Cap. Flow %
3.58%
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
1
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$19.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.8M
2
RAPT
RAPT Therapeutics
RAPT
+$2.79M

Sector Composition

Rank Sector Weight
1 Healthcare 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VEU icon
1
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$244M 62.09%
3,243,484
+253,400
+8% +$19.6M
VTV icon
2
Vanguard Value ETF
VTV
$186B
$102M 26.01%
520,000
– –
INDA icon
3
iShares MSCI India ETF
INDA
$6.83B
$17.3M 4.41%
369,600
– –
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.11B
$12.5M 3.2%
989,410
– –
FHTX icon
5
Foghorn Therapeutics
FHTX
$305M
$7.52M 1.92%
1,573,761
– –
PMVP icon
6
PMV Pharmaceuticals
PMVP
$71.5M
$3.26M 0.83%
2,627,643
– –
ALEC icon
7
Alector
ALEC
$167M
$2.81M 0.72%
1,307,858
– –
SRZN icon
8
Surrozen
SRZN
$255M
$2.55M 0.65%
87,696
– –
TNYA icon
9
Tenaya Therapeutics
TNYA
$177M
$703K 0.18%
1,015,705
– –
SRZNW icon
10
Surrozen Inc Warrant
SRZNW
$2.73K ﹤0.01%
170,833
– –
RAPT
11
DELISTED
RAPT Therapeutics
RAPT
– –
-82,234
Closed -$2.79M
SPY icon
12
State Street SPDR S&P 500 ETF Trust
SPY
$774B
– –
-4,104
Closed -$2.8M

Similar funds

WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
RC
Riposte Capital New York $392M AUM 69.08% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $392M AUM 108.45% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $392M AUM 21.9% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
BWM
Buckley Wealth Management Las Vegas, Nevada $392M AUM 28.21% 1-Year Est. Return
WSWA
Warren Street Wealth Advisors Newport Beach, California $393M AUM 23.31% 1-Year Est. Return
IPW
Inlet Private Wealth Jupiter, Florida $392M AUM 25.74% 1-Year Est. Return

Euclidean Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Euclidean Capital held 12 positions worth $392M, up 6.2% from $369M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Euclidean Capital deployed $14M of net new capital in Q1 2026, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 7.5% of assets, up from 7.4% a quarter earlier.

On the sell side, the most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $2.8M sold.

  • Euclidean Capital added most to Vanguard FTSE All-World ex-US ETF in Q1 2026, an estimated $19.6M increase.
  • Euclidean Capital fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $2.8M.
  • Euclidean Capital's ten largest holdings make up 100% of its $392M portfolio in Q1 2026.
  • Euclidean Capital opened 0 new positions and closed 2 in Q1 2026.
  • Euclidean Capital's portfolio value rose 6.2% quarter-over-quarter to $392M.

Based on Euclidean Capital's 13F filing for Q1 2026, filed 15 May 2026.